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Latent infection of human ganglia with Varicella-Zoster virus (VZV) is characterized by a highly restricted pattern of viral
gene expression. To enhance understanding of this process we used in situ hybridization (ISH) in a rat model of VZV latency
to examine expression of RNA corresponding to eight different VZV genes in rat dorsal root ganglia (DRG) at various times
after footpad inoculation with wild-type VZV. PCR in situ amplification was also used to determine the cell specificity of latent
VZV DNA. It was found that the pattern of viral gene expression at 1 week after infection was different from that observed
at the later times of 1 and 18 months after infection. Whereas multiple genes were expressed at 1 week after infection, gene
expression was restricted at the later time points when latency had been established. At the later time points after infection
the RNA transcripts expressed most frequently were those for VZV genes 21, 62, and 63. Gene 63 was expressed more than
any other gene studied. While VZV DNA was detected almost exclusively in 5–10% of neurons, VZV RNA was detected in both
neurons and nonneuronal cells at an approximate ratio of 3:1. A newly described monoclonal antibody to VZV gene
63-encoded protein was used to detect this protein in neuronal nuclei and cytoplasm in almost half of the DRG studied. These
results demonstrate that (1) this rat model of latency has close similarities in terms of viral gene expression to human VZV
latency which makes it a useful tool for studying this process and its experimental modulation and (2) expression of VZV gene
63 appears to be the single most consistent feature of VZV latency. © 2001 Academic Press
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Varicella-Zoster virus (VZV) is a human herpesvirus
which causes varicella (chickenpox) as a primary infec-
tion in susceptible individuals, who are usually children.
After this acute infection, the virus establishes a latent
infection in cells of the trigeminal ganglia and dorsal root
ganglion (DRG), following which VZV may reactivate in
later life, either spontaneously or following various trig-
gers, to cause herpes zoster (shingles) (Kennedy, 1987;
Gilden et al., 2000). The latter may be followed by post-
herpetic neuralgia and several other neurological com-
plications all of which may be associated with significant
morbidity (Johnson, 1998; Gilden et al., 2000). The cellular
site of latent VZV in human ganglia is predominantly
neuronal with a minority of nonneuronal cells infected
(Kennedy et al., 1998; Mahalingam et al., 1999; LaGuardia
t al., 1999). Knowledge of viral gene expression during
ZV latency is important both to understand the under-
ying mechanism of latency and to identify viral genes
hich could be the targets of antiviral therapy. Studies in
uman ganglia have reported consistent expression of
NA corresponding to VZV genes 21, 29, 62, and 63
Cohrs et al., 1992, 1994, 1995, 1996; Meier et al., 1993;p
t
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218Kennedy et al., 1999) and probably gene 4 (Croen et al.,
1988; Kennedy et al., 2000). VZV protein expression dur-
ing latency is also very restricted, with strong evidence
for the neuronal expression of VZV gene 63-encoded
protein in latently infected human ganglia (Mahalingam
et al., 1996; Kennedy et al., 2000), and one report of
expression of proteins encoded by several VZV genes
(Lungu et al., 1998). The extent to which other viral genes
are expressed is unclear at present, and such studies in
humans are limited to autopsy tissues.
An additional way of studying VZV latency is to use
animal models such as neonatal (Brunnell et al., 1999)
nd adult (Sadzot-Delvaux et al., 1990; Annunziato et al.,
998) rats as well as guinea pigs (Lowry et al., 1993).
lthough all of the current animal models have limita-
ions, they serve as useful tools to study VZV latency in a
echanistic way which is clearly not possible in hu-
ans. The adult rat VZV model used in this study
Sadzot-Delvaux et al., 1990) has proven useful in defin-
ng the expression of VZV gene 63 during latency (De-
rus et al., 1995). Here we determined the pattern of viral
ene expression during latency using in situ hybridiza-
ion (ISH) for a range of VZV genes on virally infected rat
RG at varying times after footpad inoculation. We hy-
othesized that viral gene expression in ganglia studied
rior to establishment of latency would be different to
hat observed in ganglia in which a latent infection had
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219VZV LATENCY IN RAT GANGLIAbeen established. Our findings provide evidence to con-
firm this postulate and extend our knowledge of gene
expression in VZV latency.
RESULTS AND DISCUSSION
We used in situ hybridization to detect RNA corre-
sponding to eight viral genes in a total of 23 rat DRG
samples obtained from 16 different rats that had been
inoculated with wild-type VZV in the footpad. The VZV
genes chosen for study spanned representative regions
of the viral genome. The DRG were studied at three time
points, namely, 1 week postinoculation, 1 month postin-
oculation, and 18 months postinoculation. The results
are shown in detail in Table 1, in which a total of eight
rats were studied at the 1-week time point, five rats were
studied at the 1-month time point, and three rats at the
18-month time point.
At the1 week postinoculation time point, RNA for VZV
genes was detected in 7 of 12 DRG. In three samples
RNA corresponding to three to six different viral genes
was detected, most frequently gene 63. In the four re-
maining DRG one to two genes were detected, again
gene 63 being the most frequent. No VZV genes were
ever detected in uninfected ganglia from four rats or
control uninfected rat liver tissue. VZV RNA was located
T
Detection by ISH of VZ
Sample Region Gene 4 Gene 18 Gene
1) DRG 1wpi Lumbar 1 1 1
2) DRG 1wpi Lumbar 2 ND 1
3) DRG 1wpi Lumbar 1 ND 2
4) DRG 1wpi Lumbar 2 ND ND
5) DRG 1wpi Lumbar 2 2 2
6) DRG 1wpi Thoracic 2 2 ND
7) DRG 1wpi Lumbar 2 2 2
8) DRG 1wpi Lumbar 2 2 2
9) DRG 1wpi Thoracic 2 2 2
0) DRG 1wpi Thoracic ND 2 ND
1) DRG 1wpi Lumbar ND 2 ND
2) DRG 1wpi Thoracic ND ND ND
3) DRG 1mpi Lumbar ND 2 2
4) DRG 1mpi Lumbar ND 2 1
5) DRG 1mpi Lumbar ND ND ND
6) DRG 1mpi Lumbar ND ND 1
7) DRG 1mpi Lumbar 2 ND ND
8) DRG 18mpi Lumbar 2 2 ND
9) DRG 18mpi Thoracic ND 2 ND
0) DRG 18mpi Thoracic ND 1 2
1) DRG 18mpi Thoracic 2 2 2
2) DRG 18mpi Lumbar 2 2 ND
3) DRG 18mpi Lumbar ND 2 ND
a DRG, dorsal root ganglion; 1wpi, 1 week post inoculation; 1mpi, 1
negative; ND, not determined.in the neuronal nuclei in most regions of tissue, but in
some regions positive signals were also detected innonneuronal cells with an approximate ratio of neuronal:
nonneuronal cells of 3:1. There were also a few regions
where only positive nonneuronal cells were seen. When
positive, the ISH signal was focal in distribution but very
approximately 5–10% of neuronal cells in the DRG sec-
tions were positive in most cases.
At the 1-month postinoculation time point fewer tissue
samples were available for analysis than at other time
points. However, most of the tissues were negative for
viral RNA expression with the exception of RNA corre-
sponding to VZV genes 63 and 21. In one sample (sample
15) gene 40 was detected. Where positive, the percent-
age of cells infected and ratio of neuronal:nonneuronal
cells positive were similar to that above and all unin-
fected control tissues were again consistently negative.
At the 18-month postinoculation time point, which was
of particular interest since viral latency would be ex-
pected to have been well established by this time, a total
of six DRG were studied in detail. It can be seen from
Table 1 that RNA corresponding to VZV genes 62 and 63
were detected in the majority of DRG. In addition, gene
18 was detected in one sample and gene 29 in another.
The percentage of infected neuronal cells (approximately
5–10%) and their predominant neuronal location (Fig. 1)
together with a smaller percentage of nonneuronal cells
in Infected Rat DRGa
Gene 28 Gene 29 Gene 40 Gene 62 Gene 63
1 1 ND ND 1
ND ND 1 ND 1
ND 1 1 ND 1
ND 2 ND ND 2
2 2 2 2 1
2 2 ND 2 2
2 2 ND 2 2
ND 2 2 2 2
2 ND ND ND 2
2 ND ND 2 1
2 ND 2 2 1
2 2 2 1 1
ND 2 2 ND 1
2 2 2 ND 2
ND 2 1 ND 1
ND ND 2 ND 1
ND ND ND ND 1
2 2 2 1 1
ND ND 2 1 2
2 ND ND 1 1
2 2 ND 1 1
2 1 2 1 1
2 ND ND 1 2
post inoculation; 18mpi, 18 months post inoculation; 1, positive; 2,ABLE 1
V RNA
21(ratio of approximately 3:1) were again similar to that
described as above.
abeled
450 in
220 KENNEDY ET AL.Although the main purpose of this study was an anal-
ysis of viral gene expression, we also used DNA PCR in
situ amplification to detect VZV DNA for genes 29 and 62
in nine DRG samples (samples 5, 7, 8, 9, 11, 18, 21, 22, and
FIG. 1. (A) PCR in situ amplification of DNA for VZV gene 62 on rat D
cells are labeled. (B) An uninfected control DRG labeled as in (A). No
on a rat DRG 18 months after footpad inoculation. Several neuronal cells
after footpad inoculation labeled with a probe to VZV gene 40. No c
monoclonal antibody to VZV gene 63-encoded protein. Some strongly l
labeled as in (E). Several neuronal cells are labeled. (Magnification, 3an uninfected control). VZV DNA was detected in six of
eight samples, with samples 7 and 18 being negative.The localization of VZV DNA was predominantly neuronal
with only occasional nonneuronal cells being positive in
the latently infected ganglia.
Since VZV gene 63-encoded protein has been previ-
eek after footpad inoculation. Several neuronal cells and nonneuronal
e labeled. (C) In situ hybridization using a probe to VZV gene 63 RNA
ew nonneuronal cells contained VZV RNA. (D) ISH on a DRG 18 months
e labeled. (E) A DRG 1 week after footpad inoculation labeled with
neuronal cells are shown with arrows. (F) A normal adult human DRG
all cases.).RG 1 w
cells ar
and a f
ells arously reported to be present in latently infected neurons
in this rat model (Debrus et al., 1995) and human ganglia
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221VZV LATENCY IN RAT GANGLIA(Mahalingam et al., 1996; Kennedy et al., 2000; Cohrs et
l., 2000), we also used a newly constructed monoclonal
ntibody to this protein to detect its presence in the
anglia. Positive staining in neuronal nuclei and cyto-
lasm was detected with this antibody in 8 of 17 ganglia
xamined (Fig. 1). The positive DRG were numbers 1, 3,
0, 11, 14, 15, 17, and 21, which represented samples at all
hree time points. In only one sample (sample 14) was 63
rotein staining not associated with expression of RNA
or gene 63. Positive staining with this antibody was not
etected in any uninfected ganglion specimens.
These results, in a putative animal model of VZV la-
ency, enhance our knowledge of this process in three
ays. First, the predominantly neuronal localization of
atent VZV DNA, as determined by the PCR in situ am-
lification technique, observed in DRG from these in-
ected rats, is in close accord with the consensus view
hat the neuron is the predominant site of latent VZV in
uman DRG and trigeminal ganglia (Mahalingam et al.,
999). The positive ganglia included three from rats
hich were studied 1 month after footpad inoculation,
hich is when latency may just have been established,
nd from one rat 18 months after inoculation, where the
resence of VZV very likely represents the establishment
f a latent infection.
Second, the pattern of VZV gene expression in the rat
RG, as determined by ISH for RNA corresponding to
ight different representative genes, bears close similar-
ties to the restricted nature of latent VZV expression in
uman ganglia. The genes known to be expressed in the
atter include genes 4, 21, 29, 62, and 63 (Cohrs et al.,
996, 2000; Kennedy et al., 2000), which is why they were
hosen for study here, and possibly, in some cases, gene
8 (Kennedy et al., 2000). In this study in rat tissues, we
bserved expression of genes 62 and 63 predominantly
s well as some occasional expression of genes 21 and
9 in ganglia which were likely to have been latently
nfected. The detection of gene 18 in sample 20 at 18-
onths postinoculation may be significant in view of the
nfrequent detection of this gene, which codes for the
mall-unit ribonucleotide reductase (Ostrove, 1990) in a
inority of human trigeminal ganglia (Kennedy et al.,
2000). While this study was limited by not studying every
selected gene in all samples, due to lack of availability of
some samples, nevertheless it was clear that RNA for
VZV gene 63, which has been reported to function as a
transactivator and transrepressor during gene regulation
(Jackers et al., 1992), was the most frequently detected in
his study, providing further evidence for the notion that
xpression of gene 63 is the hallmark of VZV latency
Cohrs et al., 2000). It should be noted, however, that a
ore recent study (Kost et al., 1995) suggested that VZV
ene 63 plays only a minor regulatory role in modulating
ZV gene expression. At the earlier 1-week-postinocula-ion time points there was no particular pattern to the
enes expressed in the positive samples, which was not
p
mnexpected as latency could not have been established
t this time, and the pattern of multiple gene expression
n sample 1 is very suggestive of a lytic viral infection.
he presence of VZV DNA in sample 7 in the absence of
ny RNA detection may reflect an early stage of viral
nfection, differing sensitivities of the DNA and RNA de-
ection assays, or, most likely, the very focal pattern of
iral infection in these tissues. While VZV RNA was
etected mainly in neurons, we observed more gene
xpression in nonneuronal cells as well in these rat
issues compared with human ganglia, but the reason(s)
or this slight but clear difference is unclear at present.
atent VZV DNA, however, was located predominantly in
eurons in these rat ganglia, as had been found previ-
usly in human ganglia (Kennedy et al., 1998; LaGuardia
t al., 1999).
Third, the detection of the VZV gene 63-encoded pro-
ein, with a newly described monoclonal antibody, in
eurons in almost half of the DRG studied provides
urther evidence for the importance of expression of this
rotein in VZV latency. This is a higher figure than the
ne of 25% positive which we had reported for this
rotein in human ganglia (Kennedy et al., 2000), and this
ay partially reflect the use of the polyvalent antibody
sed in that study. However, we recently tested this
onoclonal antibody on tissue sections of 21 normal
uman ganglia and found that eight of these, i.e., 38%,
ere positively stained (Fig. 1 and unpublished observa-
ions). The detection of 63 protein in the absence of RNA
or gene 63 in sample 14 may reflect a greater abun-
ance of protein than RNA, the focal nature of viral
nfection, or differences in the assay sensitivities.
The findings reported here indicate that further de-
ailed studies are warranted in this rat model of VZV
atency, both to enhance our understanding of the VZV
atency process and to assess the modulation of viral
atency by various methods such as mutant VZV, drugs,
r synthetic peptides.
MATERIALS AND METHODS
nimal inoculations
Animal inoculations were carried out as previously
escribed (Debrus et al., 1995). In brief, 16 six-week-old
ealthy rats were inoculated in the footpads (both sides)
ith a suspension of VZV (from a clinical isolate) -in-
ected Vero cells. Each animal received cells corre-
ponding to 25 cm2 of cells showing approximately an
0% cytopathic effect (CPE) on Vero cells. Virus titrations
arried out on Vero cells 8 days after infection for animal
noculations showed that each animal had received
bout 5 3 105 infected cells. Four uninfected rats acted
s controls. Infected rats were killed at 1 week, 1 month,
nd 18 months after the footpad inoculation, at which
oints the DRG tissues were removed and fixed in For-
alin and wax-embedded for ISH studies and immuno-
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222 KENNEDY ET AL.cytochemistry. Varying amounts of DRG tissues were
available for analysis at each time point.
Oligonucleotide probes
The probes used in this study were the same as
previously described (Kennedy et al., 2000), including
robes for VZV genes 4, 18, 21, 28, 29, 40, 62, and 63, and
ere chosen as representing both genes which have
reviously been reported as being expressed during
atency (genes 4, 21, 29, 62, and 63), and those which are
ot known to be frequently expressed during latency
genes 18, 28, and 40). All oligonucleotides were synthe-
ized by Genosys, UK.
SH and PCR in situ amplification
ISH was used to detect viral RNA, and PCR in situ
amplification was used to detect viral DNA. These as-
says were performed as previously described in detail
(Kennedy et al., 1998, 1999). In brief, for ISH assays, DRG
issue sections on glass slides were dewaxed, rehy-
rated, permeabilized with HCl and proteinase K, and
cetylated. After treatment with prehybridization buffer,
he sections were incubated overnight with the appropri-
te digoxigenin (DIG)-labeled probe and the resulting
ybrids detected using standard DIG agents. After the
lides had been dipped in the appropriate buffer, they
ere exposed to antibody conjugated to alkaline phos-
hatase, equilibrated in buffer, and treated with the de-
ection agent until the development of the purple color.
ll sides in both types of assay were read blind. The
reviously used standard controls were used, e.g., the
se of uninfected rat DRG and liver tissues, inappropri-
te or absent primer sequences, and infected CV-1 cells
Kennedy et al., 1998, 1999).
For PCR in situ amplification assays, in brief, the DRG
tissue sections were dewaxed, rehydrated, permeabil-
ized with Triton-X and proteinase K, boiled in citric acid,
fixed in acetic acid, washed, and dehydrated. Assays
were then carried out using the Perkin–Elmer Gene Amp
System 1000, with cycling parameters for VZV amplifica-
tions as previously detailed (Kennedy et al., 1998), fol-
lowing which the slides were cooled, washed, and pro-
cessed for color development as above.
Immunocytochemistry with monoclonal antibody to
VZV gene 63-encoded protein
The monoclonal antibody to VZV gene 63-encoded
protein has not been used previously, as this is the first
report using this reagent. The antibody was constructed
as follows. BALB/c mice were injected intraperitoneally
with 100 mg purified GST-IE63 (Debrus et al., 1995) emul-
sified in Freund’s complete adjuvant (Sigma, St. Louis,
MO). One month later mice were boosted with the same
amount of fusion protein and were then killed, and
splenocytes obtained by mechanical dissociation werefused in the presence of 50% polyethylene glycol with
Sp-210-Ag14 myeloma cells with a ratio of myeloma cells:
spleen cells of 1:2. After a 5-min centrifugation at 200 g,
cells were resuspended in a selection medium (Iscove’s
DMEM supplemented with 10% fetal calf serum and
hypoxanthine-aminopterin-thymidine). After 1 week cells
were plated in a 96-well plate, and supernatants were
then screened by EIA for Ig secretion. Screening was
performed on 96-well plates coated either with GST
alone as a control or with GST-IE63. Cells expressing Ig
reacting with the fusion protein but not the GST control
were selected and cloned using the limiting dilution
procedure. This procedure was repeated three times.
Two clones were selected (9A12 and 9D12) for their
ability to produce high levels of antibodies and then
produced in vivo as ascitic fluid. These antibodies can be
used for EIA, immunohistochemistry, or Western blotting
analysis. In immunohistochemistry this monoclonal anti-
body recognizes the protein in cell cultures, frozen sec-
tions fixed with acetone:ethanol at a ratio of 1:1, or
paraffin-embedded tissues. In Western blotting it hybrid-
izes to a band of 35 kDa (Fig. 2).
Immunocytochemistry was carried out as previously
described in detail (Kennedy et al., 2000). In brief, the
tissue sections on glass slides were dewaxed, rehy-
drated, and then incubated for approximately 1 h in PBS
FIG. 2. Western blot analysis of noninfected (NI) or VZV-infected (I)
cells, using the anti-IE63 monoclonal antibodies (9A12 at 1/1000) and
visualized with peroxidase-conjugated anti-mouse Ig (DAKO at 1/2000).containing 1% bovine serum albumin and 1% normal
sheep serum. Sections were then incubated at 4°C over-
B223VZV LATENCY IN RAT GANGLIAnight with mouse monoclonal antibody to VZV gene 63-
encoded protein (diluted 1:200). Slides were then
washed in PBS and incubated for 1 h with biotinylated
anti-mouse antibody in blocking buffer. After washing,
the sections were incubated with streptavidin-alkaline
phosphatase conjugate (DAKO) in blocking buffer,
washed in PBS, and then developed using NBT-BCIP or
a Fuchsin kit (DAKO) containing levamisole (0.24 mg/ml)
for 10 min. Slides were then washed, mounted in an
aqueous mountant, and read blind.
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